The cholinergic neurons in the basal forebrain give rise to a dense network of cholinergic fibers innervating the entire cortical mantle, the hippocampus, the amygdala, and some thalamic nuclei (for review, see Mesulam, 1988; Wainer and Mesulam, 1990) . Inhibiting the modulatory effect of cholinergic neurons on their target neurons has been shown to affect several behavioral domains, especially learning and memory (Olton and Wenk, 1987; Dekker et al., 199 1; Dunnett et al., 199 1; Fibiger, 1991) .
One widely used method to study the role of cholinergic neurotransmission in learning and memory has been to lesion the cholinergic basal forebrain neurons. Lesions have been produced either by physical means (radiofrequency lesion, electrolytic lesion) or by the injection of relatively more specific neurotoxic substances that damage neurons but not passing fibers (for review, see Olton and Wenk, 1987; Dekker et al., 1991) .
Chemical lesion models of the cholinergic basal forebrain system have used four different strategies: (1) basal forebrain injections of excitatory amino acids (for review, see Dekker et al., 199 1; Reine and Nieoullon, 1992) (2) injections of the aziridinium ion of ethylcholine mustard (AF64A) into the basal forebrain or target areas of cholinergic neurons (e.g., Fisher and Hanin, 1986; McGurk et al., 1987; Nakamura et al., 1992 ) (3) intracerebral or systemical injections of murine monoclonal antibodies against AChE (Bean et al., 1991; Rakonczay et al., 1993) and (4) intraventricular or intraparenchymal injections of a toxin (diphtheria toxin or the ribosome-inactivating protein saporin; Lappi et al., 1985) coupled to a monoclonal antibody directed against the ~75 NGF receptor (NGFr) (Kudo et al., 1989; Imaizumi et al., 1991; Wiley et al., 1991; Book et al., 1992; Nilsson et al., 1992; Wiley, 1992) .
The ~75 NGF receptor is a 75 kDa transmembrane protein without tyrosine kinase activity that binds all neurotrophins known to date; NGF, brain-derived neurotrophin factor, and neurotrophin-3, -4, and -5 (Bothwell, 199 la; Chao, 1992) . Most importantly, for the present study, the cholinergic basal forebrain neurons have been shown to express by far the highest level of p75 NGFr immunoreactivity in the adult rat brain (Kiss et al., 1988; Koh et al., 1989; Woolf et al., 1989; Yan and Johnson, 1989; Pioro and Cuello, 1990a,b; Bothwell, 199 lb) . Furthermore, it was demonstrated that the p75 NGF receptor mediates the retrograde transport of both neurotrophins and a monoclonal antibody against the p75 NGF receptor (Schweitzer, 1987; Altar and Bakhit, 199 1; Ferguson et al., 199 1) . Therefore, injection of a toxin-coupled antibody targeting this epitope was regarded as a very promising lesion model of the cholinergic basal forebrain system (Wiley, 1992 ).
Here we report on the extent, time course, specificity, and mechanism of the cholinergic basal forebrain lesion induced by intraventricularly or intraparenchymally injected saporin, coupled to an antibody against the p75 NGF receptor (192 IgGsaporin), in the adult rat CNS.
Materials and Methods Animals and injections
Eighty-one male albino Sprague-Dawley rats (250-400 gm) were used for stereotaxically placed injections of a 0.42 mg/ml solution of 192 IgG-saporin, a solution of the monoclonal antibody 192 IgG, a 0.06 M ibotenic acid solution, a 0.1 M quisqualic acid solution, or a 0.9% saline solution. The production of the 192 IgG-saporin solution is described elsewhere' (Wiley et al., 199 1; Wiley and Lappi, 1993) .
Animals were anesthetized with 6.5 mg/lOO mg body weight sodium pentobarbital and placed in a stereotaxic apparatus. For each injection, a hole was drilled in the skull and a microliter syringe filled with toxin or saline solution was lowered at three different locations. Coordinates were taken from Paxinos and Watson (1986) .
Zntruventriculur injections. 192 IgG-saporin solution (4-10 ~1) was injected at AP -1.0, ML + 1.5, and DV -4.5 relative to bregma (n = 16). Control animals (n = 9) received equivalent amounts ofsaline.
Septul ejections. 192 IgG-saporin solution (0.3-0.5 ~1) (n = 9) or saline (n = 5) was injected into the septal nuclei at an angle of 15" at AP +0.6, ML -1.5, and DV -6.7 relative to bregma.
Substantiu innominuta injections. 192 IgG-saporin solution (0.3-0.7 ~1) (n = 25) 1 ~1 solution of the monoclonal antibody 192 IgG against the ~75 NGF receptor (n = 4), 1 ~1 ibotenic acid solution (n = l), 1 ~1 quisqualic acid solution (n = 9), or 0.3 ~1 saline solution (n = 3) was injected into the substantia innominata at AP -0.9, ML k2.8, and DV -7.2 relative to bregma. lntraventricular and septal injections were always single injections; substantia innominata injections were performed unilaterally as well as bilaterally. Animals were allowed to survive for 1, 2, 3, 4, or 5 d (n = 2 for each group), 7 d (n = 13), 14 d (n = 5), 22 d (n = 37) 28 d (n = 7), or 180 d (n = 9).
Preparation of tissue sections
Animals were anesthetized with an overdose of sodium pentobarbital (13 mg/lOO mg body weight) and perfused transcardially with 50-100 ml 0.9% saline, followed by either 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4), or 4% paraformaldehyde with 0.5% glutaraldehyde and 15% saturated picric acid solution in 0.1 M phosphate buffer (pH 7.4) for 20 min, and finally with 100 ml of a 10% sucrose solution.
Some brains were not perfused with the 10% sucrose solution but were postfixed in the 4% paraformaldehyde with 0.5% glutaraldehyde and 15% saturated picric acid solution in 0.1 M phosphate buffer for 2 hr. All brains were immersed in a 30% sucrose solution overnight at 4°C cut on a freezing microtome into 40-Km-thick sections, and stored in a 0.1 M phosphate buffer solution containing 0.02% sodium azide at 4°C.
Stains
One series of sections per animal was mounted on chromalum-subbed slides, air dried, and Nissl stained in a 0.1% cresyl violet solution for 5 min.
Enzyme histochemistry. One series of sections per animal was mounted on chromalum-subbed slides, air dried, and stained for acetylcholinesterase (AChE) using the Tago modification of the Kamovsky-Roots histochemical procedure (Tago et al.,' 1986; Mesulam and Moran, 1987 nonacetylcholinesterases, 0.0072 gm of ethopropazine was added to the incubation solution. After 50-60 min the incubation was stopped by rinsing in 0.1 M Ttis buffer, pH 7.6. The sections were then soaked in a solution of 0.008 gm of cobalt chloride in 100 ml of Tris for 10 min, rinsed again in the Tris buffer, and finally incubated for 10 min in a solution of 0.05 gm of diaminobenzidine (DAB) in 100 ml of Tris with 3.3 ml of 0.3% HzOz solution added. The sections were taken through a final rinse, dehydrated, and coverslipped with permount.
Sections of selected animals were stained free floating for reduced nicotinamide-adenine dinucleotide phosphate diaphorase (NADPHd) activity according to the direct method of Scherer-Singler et al. (1983) . Briefly, sections were rinsed in 0.1 M Tris buffer, pH 8.0 and then incubated in a solution containing 0.8% Triton X-100, 8 mM L-malic acid (monosodium salt), 0.5 mM reduced NADPH (tetrasodium salt), and 0.8 mM nitro blue tetrazolium in the same Tris buffer at 37°C. The incubation was stopped after 1 O-l 5 min by rinsing in the Tris buffer and then the sections were mounted, air dried, dehydrated, and coverslipped with permount.
Immunohistochemistry. Immunohistochemical staining using a monoclonal antibody to bovine ChAT (Ab8) was carried out using the peroxidase-antiperoxidase (PAP) method of Sternberger (1986). All other immunohistochemical stains were performed following the avidinbiotin ABC procedure (Hsu et al., 198 1) .
The basic ABC immunohistochemical procedure was as follows: free- floating sections were rinsed in 0.1 M phosphate-butlered saline, treated with 0.4% Triton X-100 in PBS for 1 hr, soaked in carrier medium consisting of 3% goat serum and 0.1% Triton X-100 in PBS for 1 hr, and subsequently incubated in solutions of primary antibodies in carrier medium for 24-72 hr at 4°C. After rinsing, the sections were incubated in appropriate solutions of biotinylated secondary antibodies (1:500) in carrier medium for 24 hr at 4°C. The sections were then rinsed again and transferred to a 1: 100 solution of peroxidase-labeled avidin-biotin complexes in carrier medium for 2 hr. After a final rinse in 0.05 M Tris buffer, the sections were exposed to a solution of 0.005% DAB and 0.01% Hz02 in 0.05 M Tris buffer, pH 7.6. Monoclonal antibodies (and their concentrations) used in the present study were directed against (1) purified ~75 NGF receptors (1:500) and (2) the calcium-binding protein parvalbumin purified from carp muscle (1:2000) (Sigma Chemical Co., St. Louis, MO). Polyclonal antibodies used were directed against (1) human placental ChAT (1: 1000) (2) the vitamin D-dependent calcium-binding protein calbindin-D,,, (1:5000), (3) the enzymes tyrosine hydroxylase (TH) (1: 1000) and (4) dopamine-P-hydroxylase (DBH) (1: 1000) (both from Eugene Tech, Allendale, NJ), and (5) the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT) (1: 1000) (Incstar, Stillwater, MN).
In some cases, the DAB polymers were intensified using a modified Fontana-Masson method (Masson, 1928) . As described by Kitt et al. (1988) the sections were incubated in a 2.5% silver nitrate solution, and then placed in a 0.2% gold chloride solution and fixed in 5% sodium thiosulfate.
Analysis
Sections were examined using bright-field and dark-field microscopy. The extent of the cholinergic basal forebrain lesion was judged qualitatively by careful analysis of serial sections (stained for cresyl violet, NGFr, ChAT, and AChE) through the entire forebrain, brainstem, and cerebellum. Selected sections were charted with the aid of a plotter connected to the movable stage of a microscope via a computer (Microplotter 4000+, DiLog Instruments, Tallahassee, FL). The specificity of the lesion for cholinergic basal forebrain neurons was studied with serial, adjacent sections stained for NGFr, ChAT, AChE, parvalbumin, calbindin-D,.,. NADPHd. TH. and DBH. Unilateral 192 IaG-sanorin _".., --injections into the substantia innominata were compared with the contralateral saline injection. Intraventricular, septal, and bilateral substantia innominata injections were compared with saline injections at the same coordinates. Cortical areas were delineated according to the classification of Zilles (Paxinos and Watson, 1986) . Cholinergic neurons were classified according to the nomenclature proposed by Mesulam et al. (Mesulam et al., 1983; Rye et al., 1984) .
Results

General observations
The male Sprague-Dawley rats used in the present study tolerated intraventricularly (3.36 or 4.2 pg) as well as intraparenchymally (0.126 Kg) injected 192 IgG-saporin. Most animals showed weight loss or a decreased weight gain in the first week after surgery. We observed no fatalities of animals that had recovered from the pentobarbital anesthesia.
How complete is the degeneration of cholinergic basal forebrain neurons?
NGFr-positive basal forebrain neurons
The strong perikaryal immunoreactivity for the ~75 NGF receptor in the cholinergic basal forebrain neurons was unchanged after intraventricular or intraparenchymal saline injections ( Fig.  lA-C) . In these animals, a dense network of NGFr-positive fibers could be observed in target areas of the cholinergic basal forebrain neurons, including the entire cortical mantle and the hippocampus ( Fig. 2A,B) , as well as parts ofthe amygdala. NGFr immunoreactivity was unaltered in rats after intraparenchymal injections of only the 192 IgG antibody into the substantia innominata (data not shown).
192 IgG-saporin injections into the ventricle induced an almost complete and bilateral loss of perikaryal NGFr immunoreactivity in the basal forebrain (Fig. l&F) . Some sections displayed two or three residual NGFr-positive neurons in the basal forebrain (Fig. 1D) . No NGFr-positive axonal staining was seen in cortex, hippocampus (Fig. 2C,D) , or amygdala. Time course. The loss of ChAT-positive basal forebrain neurons was first seen 2 d after 192 IgG-saporin injection into the substantia innominata and gradually increased over the next 5 d (Fig. 6) . The extent of the lesion and the distribution of residual cholinergic neurons as described above were observed mainly in animals killed after 22 d (Figs. 3, 4) . The pattern remained unchanged in animals 180 d after 192 IgG-saporin injection.
AChE-positiveJibers
The histochemical reaction product for AChE can be used as a marker for cholinergic fibers in the rat cortex with the exception of a few cortical areas, such as the retrosplenial cortex and somatosensory barrel fields (Lysakowski et al., 1989) . Target areas of the cholinergic basal forebrain neurons, such as the hippocampus, the olfactory bulb, the cortex, and the amygdala, displayed a high density of AChE-positive fibers (Figs. 7A; 8A-C, 9A,R). This pattern was unchanged after saline injection.
Intraventricular injection of 192 IgG-saporin. The olfactory bulb, the projection target for the Ch 3 group, showed a complete loss of AChE-positive fibers (Fig. 8D) . The hippocampus and cingulate cortex, recipients of cholinergic fibers from the Ch 1 and Ch 2 group, displayed a complete loss of AChE-positive fibers (Figs. 7, 8E) . A dense band of AChE activity, observed in the retrosplenial cortex of control rats (Figs. 7A, K' ), did not disappear after 192 IgG-saporin injection (Figs. 7B, 8F) . Frontal, temporal, parietal, and occipital isocortex, innervated by the Ch 4 group, displayed an almost complete loss of AChEpositive fibers (Fig. 7B) . Paralimbic cortical areas (insular cortex, perirhinal cortex, piriform cortex, and entorhinal cortex), which are also innervated by the Ch 4 group, displayed only a partial loss of AChE-positive fibers (Fig. 9C) . AChE-positive fibers in the amygdala, a target area of cholinergic neurons of the Ch 4 group, were essentially unchanged 3 weeks after 192 IgG-saporin injection (Figs. 7B, 9D ). The lesioned animals in which ChAT-positive cortical and hippocampal fibers could be visualized confirmed the pattern of cholinergic denervation as seen with AChE histochemistry. The upper layer 3 of the retrosplenial cortex displays a band of much stronger AChE activity than the adjacent layers 2 and lower layer 3 (Figs. 7; 8CJ'). ChAT-positive fibers, however, are much denser in layers 2 and lower layer 3 (data not shown). Therefore, we considered the band of strong AChE activity in the upper layer 3 of the retrosplenial cortex to be noncholinergic.
Intraparenchymal injection of I92 IgG-saporin. Septal injections induced a complete loss of AChE-positive fibers in the entire hippocampus and in medial and directly adjacent cortical areas (cingulate cortex, retrosplenial cortex, frontal cortex, forelimb and hindlimb areas, and occipital cortex). Bilateral substantia innominata injections induced the same degree of neocortical deafferentiation as the intraventricular injections and produced only mild to moderate loss of AChE-positive fibers in the hippocampus. The AChE-positive innervation of the basolateral nucleus of the amygdala and the nucleus of the lateral olfactory tract was essentially unchanged, whereas the remaining amygdaloid nuclei showed some loss of AChE-positive fibers.
Comparison to excitatory amino acid lesions. Injections of 192 IgG-saporin into the substantia innominata reduced the density of AChE-positive fibers in the cortex more completely than ibotenic acid and quisqualic acid injections (Fig. 10) . 192 IgG-saporin injections caused a depletion of AChE-positive fibers throughout the neocortical mantle, whereas excitatory amino acids caused a more restricted depletion, probably confined to the cortical projection areas ofthe cholinergic neurons around the injection site.
Time course. This pattern of AChE-positive fiber loss, observed in animals 22 d after lesioning, developed gradually over the first 5 d after 192 IgG-saporin injection into the substantia innominata. It was essentially unchanged 180 d after 192 IgGsaporin injections into the ventricle or the substantia innominata.
How specific is the lesion for basal forebrain cholinergic neurons?
NGFr-positive structures outside the basal forebrain All structures expressing the ~75 NGF receptor can be expected to be affected by 192 IgG-saporin injections. We studied the effect on four different structures outside the basal forebrain the ventricle or intraparenchymally into the substantia innomithat either revealed NGFr immunoreactivity in our material or nata and septal nuclei (Fig. 11A) . for which such evidence is reported in the literature (Pioro and The raphe nuclei, reported to express low levels of NGFr Cuello, 1988 Cuello, , 1990b Altar, 199 1) : the mesencephalic trigeminal immunoreactivity in the adult rat brain (Pioro and Cuello, nucleus, the raphe nuclei in the medulla oblongata, the Purkinje 1990a), did not show prominent staining in our material. In cells of the cerebellum, and the cholinergic neurons of the neosections stained for S-HT, no difference could be observed comstriatum.
paring control animals with animals after intraventricular 192 The mesencephalic trigeminal nucleus displayed the highest IgG-saporin injections (Fig. 11B) . . . , -by using the calcium-binding protein calbindin-D,,,, which is expressed in Purkinje cells of normal rats (Fig. 12B) . After intraventricular 192 IgG-saporin injections, no residual NGFr staining could be observed in the cerebellum (Fig. 12C) . Intraventricular 192 IgG-saporin injections induced an almost complete loss of calbindin-D,,, immunoreactivity in the dorsalmost folium and a band-like loss of immunoreactivity in more ventral folia (Fig. 120) . Careful analysis of Nissl-stained sections revealed a loss of Purkinje cells in exactly those bands of lost calbindin-D,,, immunoreactivity.
Injections of 192 IgG-saporin into the septal area or the substantia innominata did not change the calbindin-D,,, immunoreactivity in the cerebellum. We did not observe NGFr immunoreactivity in the neostriatum of the adult rat. Rats followed for up to 180 d after intraventricular 192 IgG-saporin injections showed neither signs of degeneration in Nissl-stained material nor a loss of ChATpositive striatal neurons. However, in rats that had received 192 IgG-saporin injections into the substantia innominata, a significant loss of ChAT-positive striatal interneurons could be observed. This was especially pronounced in cases followed for 180 d after injection (Fig. 13 ). This loss of cholinergic striatal interneurons seemed to be specific, since striatal NADPHdpositive neurons were not affected by ventricularly or parenchymally injected 192 IgG-saporin (data not shown).
NGFr-negative structures
We studied three neuronal populations of special interest with regard to the specificity of a cholinergic basal forebrain lesion after 192 IgG-saporin injection: (1) ChAT-positive structures outside the basal forebrain, (2) noncholinergic basal forebrain neurons, and (3) noncholinergic cell groups diffusely projecting to the cortex.
ChAT-positive neurons in cortex, epithalamus, and brainstem. A subpopulation of cortical interneurons expressed ChAT immunoreactivity in the adult rat brain. These neurons did not express NGFr immunoreactivity and were not affected after 192 IgG-saporin injections (Fig. 14A) .
Cholinergic neurons of the pedunculopontine nucleus (Ch 5 group), the laterodorsal tegmental nucleus (Ch 6 group), and the medial habenula (Ch 7 group) did not display NGFr staining and were unaffected by 192 IgG-saporin injections (Fig. 14B,C) . The same was true for the ChAT-positive motor nuclei of the pons and medulla oblongata (motor trigeminal nucleus, dorsal motor vagal nucleus, facial nucleus, hypoglossal nucleus).
Noncholinergic basal forebrain neurons. Cholinergic neurons in the medial septum and diagonal band of Broca are adjacent to noncholinergic neurons expressing the calcium-binding protein parvalbumin (Fig. 15A,B) . Intraventricular injections of 192 IgG-saporin, which induced a complete loss of cholinergic neurons in the septum, did not change the immunoreactivity for parvalbumin in these midline septal neurons (Fig. 15C,D) .
Cholinergic neurons of the Ch 3 and Ch 4 groups are adjacent to noncholinergic neurons expressing the calcium-binding protein calbindin-D,,, (Fig. 16A,B) . (Fig. 16C,D) .
The majority of neurons in the medial septum and vertical limb of the diagonal band that express NADPHd activity are cholinergic. In the horizontal limb of the diagonal band and the substantia innominata, however, many NADPHd-positive neurons do not express ChAT immunoreactivity. A normal distribution of NADPHd-positive neurons was found after intraventricular 192 IgG-saporin injections in areas devoid of any ChAT-positive Ch 3 or Ch 4 neurons (data not shown). The distribution of parvalbumin-, calbindin-D,,,-, and NADPHd-positive basal forebrain neurons was also studied in rats after injection of 192 IgG-saporin into the septal area or the substantia innominata. Tissue damage due to the needle tract and high background immunoreactivity precluded an analysis of parvalbumin-and calbindin-positive neurons in the immediate vicinity of the injection site. Nissl-stained sections revealed a stronger gliotic reaction around the injection site compared to intraventricular 192 IgG-saporin injections. However, in all cases studied, numerous parvalbumin-positive septal and diagonal band neurons as well as calbindin-D,,,-and NADPHd-positive neurons in the nucleus basalis-substantia innominata complex were observed in areas totally devoid of ChAT-and NGFr-positive basal forebrain neurons. DBH-positive and TH-positive neurons. Dopaminergic and noradrenergic neurons were assessed by using antibodies against TH and DBH (Fig. 17) . Animals followed up to 22 d after intraventricular or intraparenchymal injections of 192 IgG-saporin did not show changes of perikaryal immunoreactivity or in the dense noradrenergic and dopaminergic innervation of cortical areas that had been depleted of cholinergic fibers (Fig.  17B,D) .
How does the toxin-coupled antibody reach its target? We injected a mixture of 192 IgG-saporin (1.68 Kg) and colchicine (2 pg) (n = 2) or just 192 IgG-saporin (1.68 Kg) (n = 1) into the ventricle of three animals. The colchicine/l92 IgGsaporin-treated rats showed normal fiber density over the entire cortex contralateral to the injection site (Fig. 18A ) and some fiber loss ipsilaterally. The animal injected with only 192 IgGsaporin showed complete bilateral loss of AChE-positive fibers in isocortex and hippocampus (Fig. 18B ). saporin in the adult rat brain. Intraventricular and intraparenchymal injections induced a complete loss of NGFr-positive cholinergic neurons projecting to the neocortex and hippocampus. NGFr-negative cholinergic neurons of the nucleus basalissubstantia innominata complex were not affected. 192 IgG-saporin proved to be relatively specific for NGFr-positive cholinergic basal forebrain neurons since noncholinergic basal forebrain neurons, noncholinergic cortical afferents, and cholinergic neuronal groups outside the basal forebrain were preserved. However, two neuronal groups outside the basal forebrain that express the p75 NGF receptor, cerebellar Purkinje cells and cholinergic striatal interneurons, were vulnerable to injury by 192 IgG-saporin.
Extent of cholinergic basal forebrain lesions
In previous studies, mechanical lesions or local injections of neurotoxins into the basal forebrain produced an incomplete cholinergic deafferentiation of cortex and hippocampus (for review, see Olton and Wenk, 1987; Smith, 1988; Dekker et al., 1991; Dunnett et al., 1991; Reine and Nieoullon, 1992) . This is in line with our experiments and those of others (Robbins et al., 1989) demonstrating that injections of various concentrations of ibotenic acid or quiqualic acid into the substantia innominata do not induce a complete loss of AChE-positive fibers in cortex and hippocampus. The more complete cholinergic denervation after intraparenchymal 192 IgG-saporin injections could be due to uptake by local collaterals and retrograde transport into the other neurons of the Ch l-4 complex. For example, injections into the substantia innominata always reached all NGFr-positive Ch 4 neurons in the nucleus basalis-substantia innominata complex and also spread to the Ch l-3 neurons. Intraventricular injections reached virtually every cholinergic basal forebrain neuron that expressed the p75 NGF receptor. This seems to be mediated by terminal uptake and retrograde transport to the soma as demonstrated by the protection of NGFr-positive basal forebrain neurons by simultaneous injec- Several studies have reported a reemergence of cortical ChATlevels after basal forebrain lesions (see Table 4 in Dekker et al., 199 1) . This was interpreted as collateral compensatory sprouting of residual cholinergic fibers after partial lesion of the cholinergic basal forebrain neurons (Olton and Wenk, 1987) . Anatomical studies have provided evidence for (Gage et al., 1983) and against (Mufson et al., 1987; Batchelor et al., 1989; Henderson, 199 1) such a compensatory process. In keeping with the findings ofMufson et al. (1987) we did not observe any recovery of cholinergic fibers. This may be due to the extensive lesion of cholinergic basal forebrain neurons.
We observed an extensive number of AChE-positive cortical neurons after 192 IgG-saporin injections. Furthermore, the number of ChAT-positive cortical interneurons was unchanged after complete cholinergic denervation. This supports the suggestion that the residual ChAT and AChE activity seen in biochemical assays of cortical samples after extensive basal forebrain lesions is due, at least in part, to intrinsic cortical neurons (Olton and Wenk, 1987; Book et al., 1992; Nilsson et al., 1992) .
Heterogeneity of cholinergic basal forebrain neurons
Although injections of 192 IgG-saporin into the ventricle or the substantia innominata induced a complete loss of neocortical cholinergic fibers, a considerable number of cholinergic neurons and limbic cholinergic fibers were not affected. These neurons did not express the ~75 NGF receptor and were localized mainly in the ventral pallidum and ventral to the lenticular nucleus (sublenticular substantia innominata according to Carlsen et al., 1985) . Previous studies have demonstrated such a population of ChAT-positive, NGFr-negative neurons in the nucleus basalis-substantia innominata complex of the rat (Dawbarn et al., 1988; Kiss et al., 1988; Batcheloret al., 1989; Woolfet al., 1989; Bickel and Kewitz, 1990) . It is very likely that those residual ChAT-positive, NGFr-negative neurons give rise to the dense cholinergic innervation of the amygdala and parts of the rhinal paralimbic areas that were spared or only partially affected by 192 IgG-saporin injections (S. Heckers and M.-M. Mesulam, unpublished observation). This is in accordance with studies on Figure 16 . Specificity of damage to Ch 4 neurons after intraventricular 192 IgG-saporin injection. A, Saline-treated rats display ChAT-positive neurons in the putamen (p) and two compartments of the Ch 4 complex, medial to the globus pallidus (gp) and in the medullary stria, interspersed between putamen and globus pallidus. B, In the same animal, small perikarya and fibers immunoreactive for calbindin-D,,, are located in the medullary stria and adjacent putamen. C, Twenty-two days after intraventricular 192 IgG-saporin injection, the cholinergic neurons in the putamen are unchanged, whereas almost all Ch 4 neurons are lost. D, In the same animal, the calbindin-D ,,,-positive neurons (curved arrows) are unchanged. Scale bar, 200 pm. the basal forebrain afferents to the amygdala in the rat (Nagai et al., 1982; Woolf and Butcher, 1982; Carlsen et al., 1985; Luiten et al., 1985 Luiten et al., , 1987 Rao et al., 1987; Henderson and Evans, 199 1) . It is of interest that the heterogeneity of cholinergic neurons in the nucleus basalis-substantia innominata complex with regard to ~75 NGF receptors coincides with a clear distinction in the projection pattern of these two groups of neurons. It is not clear whether such a correlation exists for other heterogeneous chemical markers of rat basal forebrain neurons such as galanin or NADPHd (Pasqualotto and Vincent, 199 1; Geula et al., 1993) . However, there seems to be a differential vulnerability of cholinergic basal forebrain neurons to excitatory amino acids. For example, Boegmann et al. (1992) demonstrated that oc-amino-3-hydroxy-4-isoxazole propionic acid (AMPA) and quisqualic acid injections into the nucleus basalis reduce ChAT activity primarily in the cortex whereas quinolinic acid and ibotenic acid injections reduce ChAT activity primarily in the amygdala. This might be due to the differential expression of glutamate receptor types on cholinergic basal forebrain neurons projecting to the amygdala or the cortex. Such a heterogeneity could explain why AMPA and quisqualic acid injections, which leave cholinergic neurons projecting to the amygdala relatively intact, produce only marginal impairments in cognitive tasks that are significantly impaired after ibotenic acid injections (Dunnett et al., 199 1; Boegmann et al., 1992) .
SpeciJicity of cholinergic basal forebrain lesions
Our experiments demonstrate that 192 IgG-saporin spares three groups of noncholinergic and one group of cholinergic basal forebrain neurons: (1) parvalbumin-positive, presumably GABAergic (Freund, 1989) septal neurons that are intermingled with cholinergic neurons of the Ch 1 and Ch 2 group (Alonso et al., 1990; Kiss et al., 1990a,b; Brauer et al., 199 l) , (2) cholinergic (Pasqualotto and Vincent, 1991; Geula et al., 1993) , shrinkage or neuronal loss in any of these noncholinergic neuand (4) NGFr-negative, ChAT-positive neurons of the Ch 4 ronal groups comparing 192 IgG-saporin injections with saline group. Our analysis of these four groups of spared neurons was injections, we cannot exclude relatively small quantitative difbased on a qualitative comparison of serial sections through the ferences in perikaryal size or neuronal density. entire forebrain. Although we did not observe any neuronal
Parenchymal 192 IgG-saporin injections induced a more pro- nounced gliosis than intraventricular injections. Because of the gliosis and increased background immunoreactivity we could not ascertain that the noncholinergic neurons were as completely preserved after parenchymal injections as after intraventricular injections. Furthermore, substantia innominata injectiorrs also led to damage of striatal cholinergic neurons. Thus, the specificity of the lesion for cholinergic basal forebrain neurons may be less after parenchymal than intraventricular 192 IgG-saporin injection.
In the rat brain, the ~75 NGF receptor is also expressed outside the basal forebrain, notably in the mesencephalic trigeminal nucleus, cerebellar Purkinje cells, and striatal neurons Cuello, 1988, 1990a,b; Koh et al., 1989; Yan and Johnson, 1989; Altar, 1991; Bothwell, 1991b; Koh and Higgins, 1991; von Bartheld and Bothwell, 1993) . There is evidence from in vivo and in vitro experiments that a population of noncholinergic, presumably GABAergic, basal forebrain neurons might also express the ~75 NGF receptor Dreyfus et al., 1990) .
We found that 192 IgG-saporin injections affected two of these neuronal groups, cerebellar Purkinje cells after intraventricular injections and cholinergic striatal interneurons after basal forebrain injections. A subset of cerebellar Purkinje cells starts expressing the p75 NGF receptor during development and continues during adulthood Cuello, 1988, 1990b; Koh and Higgins, 1991) . Striatal neurons express the ~75 NGF receptor in early development but decrease the expression drastically during adulthood (Pioro and Cuello, 1990a; Altar, 199 1; Koh and Higgins, 1991) . The loss of striatal neurons might be due to the lesion-induced reexpression of ~75 NGF receptors in the striatum . Striatal NADPHd-positive neurons were not affected by local injections. This is in line with previous observations that the ~75 NGF receptor in the striatum is expressed primarily by cholinergic neurons (Altar, 199 1) .
Most previous lesion studies of the basal forebrain did not find significant differences in noncholinergic neurotransmitter systems during the first months after basal forebrain lesions (for review, see Dekker et al., 199 1; Reine and Nieoullon, 1992) . The present study also did not find changes in the noradrenergic and dopaminergic fiber density in the cortex and hippocampus, which is in agreement with previous studies of the 192 IgGsaporin lesion model (Book et al., 1992; Nilsson et al., 1992) .
In conclusion, 192 IgG-saporin appears to induce more complete lesions of neocortical and hippocampal cholinergic afferents than other previous lesion and toxin models. Lesions of other neuronal systems seem to be restricted to either cerebellar (after intraventricular injection) or striatal (after basal forebrain injection) neurons that present the ~75 NGF receptor to the injected immunotoxin. The complete, selective, and relatively specific lesions induced by 192 IgG-saporin injections may be a useful tool to study the anatomical heterogeneity, physiology, and behavioral implications of the cholinergic basal forebrain system.
